ICD implantation within 40 days of myocardial infarction
ICD Guidelines Microchapters |
Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities |
Expert Consensus on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials |
ICD Implantation in the Context of an Abnormal Troponin that is Not Due to a Myocardial Infarction |
ICD Implantation Less Than 9 Months From The Initial Diagnosis of Nonischemic Cardiomyopathy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2]
ICD Implantation Within 40 Days Of a Myocardial Infarction[1]
Recommended |
"1. In patients who, within 40 days of an MI, require nonelective permanent pacing, who also would meet primary prevention criteria for implantation of an ICD, and recovery of left ventricular function is uncertain or not expected, implantation of an ICD with appropriately selected pacing capabilities is recommended." |
"2. In patients who, within 40 days of an MI, develop sustained (or hemodynamically significant ventricular tachyarrhythmias >48 hours after an MI and in the absence of ongoing ischemia, implantation of an ICD is recommended. " |
"3. In patients within 40 days of an MI and who have an ICD that requires elective replacement due to battery depletion, after careful assessment of comorbidities and the current clinical situation, replacement of the ICD generator is recommended." |
Can be Useful |
"1. In patients who, within 40 days of an MI, develop sustained (or hemodynamically significant) VT >48 hours after an MI that can be treated by ablation, implantation of an ICD can be useful." |
"2. In patients who, within 40 days of an MI, present with syncope that is thought to be due to ventricular tachyarrhythmia (by clinical history, documented NSVT, or electrophysiologic study), implantation of an ICD can be useful." |
Not Recommended |
"1. Implantation of an ICD within the first 40 days following acute MI in patients with preexisting systolic ventricular dysfunction (who would have qualified for a primary prevention ICD) is not recommended. " |
"2. In patients who, within 40 days of an MI, develop sustained (or hemodynamically significant) ventricular tachyarrhythmias where there is clear evidence of an ischemic etiology with coronary anatomy amenable to revascularization (and appropriately treated), implan- tation of an ICD is not recommended." |
"3. ICD implantation in patients within 40 days of an MI who have been listed for heart transplant or implanted with a left ventricular assist device is not recommended." |
- ↑ Kusumoto FM, Calkins H, Boehmer J, Buxton AE, Chung MK, Gold MR, Hohnloser SH, Indik J, Lee R, Mehra MR, Menon V, Page RL, Shen WK, Slotwiner DJ, Stevenson LW, Varosy PD, Welikovitch L (2014). "HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials". J. Am. Coll. Cardiol. 64 (11): 1143–77. doi:10.1016/j.jacc.2014.04.008. PMID 24820349.